NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Sep 30
In fiscal 2025, NEUROONE MEDICAL TECHNOLOGIES Corp reported revenue of $9.10M, up 163.5% from the prior year. The company ran a net loss, with a net margin of -39.6% and a gross margin of 56.5%. It held $10.79M in total assets against $3.71M in total liabilities.
Key ratios (FY2025)
56.5%
Gross margin
-46.5%
Operating margin
-39.6%
Net margin
-51.0%
Return on equity
+163.5%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.10M | $3.45M | $1.95M | $171.2K | $178.1K | — | — | — | — | — |
| Cost of Revenue | $3.96M | $2.37M | $1.50M | $242.0K | $275.9K | — | — | — | — | — |
| Gross Profit | $5.14M | $1.08M | $456.5K | -$70.8K | -$97.7K | — | — | — | — | — |
| Operating Income | -$4.23M | -$11.89M | -$11.96M | -$10.03M | -$10.22M | -$4.90M | -$5.81M | — | -$3.07M | -$32.6K |
| Net Income | -$3.61M | -$12.32M | -$11.86M | -$10.00M | -$9.95M | -$13.64M | -$6.78M | — | -$5.06M | -$47.8K |
| EPS (Diluted) | $-0.09 | $-0.46 | $-0.65 | $-0.63 | $-0.93 | — | — | — | — | — |
| Total Assets | $10.79M | $5.37M | $8.10M | $12.82M | $7.94M | $4.76M | $532.6K | $218.7K | $250.0K | $756.9K |
| Total Liabilities | $3.71M | $4.55M | $1.85M | $3.22M | $1.38M | $2.69M | $1.77M | $4.61M | $5.29M | $1.02M |
| Shareholders' Equity | $7.07M | $822.0K | $6.25M | $9.60M | $6.55M | $2.07M | -$1.24M | -$4.40M | -$5.04M | -$266.2K |
| Cash & Equivalents | $6.57M | $1.46M | $5.32M | $8.16M | $6.90M | $4.04M | $260.7K | $13.3K | $26.5K | $522.2K |
| Operating Cash Flow | -$2.84M | -$11.01M | -$12.89M | -$7.52M | -$8.60M | -$3.43M | -$5.40M | — | -$2.11M | — |
| Capital Expenditures | $81.7K | $120.2K | $384.1K | $275.2K | $67.1K | $122.4K | $58.4K | — | — | — |
| Shares Outstanding | 50.01M | 30.82M | 23.93M | 16.22M | 12.01M | 7.39M | 13.49M | 9.66M | 7.86M | 5.22M |